Mahesh Asawa Chandra
Director/Board Member at Unidrug Innovative Pharma Technologies Ltd.
Profile
Mahesh Asawa Chandra is currently an Independent Director at Unidrug Innovative Pharma Technologies Ltd.
and a Fellow Member at The Institute of Chartered Accountants of India.
He has an undergraduate and graduate degree from Devi Ahilya University.
Mahesh Asawa Chandra active positions
Companies | Position | Start |
---|---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Director/Board Member | 2018-09-19 |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
Training of Mahesh Asawa Chandra
Devi Ahilya University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Unidrug Innovative Pharma Technologies Ltd.
Unidrug Innovative Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Unidrug Innovative Pharma Technologies Ltd. engages in the manufacture of active pharmaceutical ingredients and its intermediates. Its products include Allopurinol, Alprazolam, Disulfiram, Etamsylate, Mefenamic Acid, Nitazoxanide, Propanolol HCL, Tinidazole, Baclofen, Guaifenesin and Ornidazole. The company was founded on March 13, 1987 and is headquartered in Indore, India. | Health Technology |
- Stock Market
- Insiders
- Mahesh Asawa Chandra